Corporate News – Market Activity and Company Overview

Share Price Movements

StockChange (24 h)Current PriceMarket Capitalisation
DR Horton Inc. (DHI)–0.85 %USD 146.72USD 38.9 bn
Ferguson Enterprises Inc. (FERG)+0.39 %USD 227.58USD 44.1 bn
Idexx Laboratories Inc. (IDXX)–0.80 %USD 566.02USD 44.0 bn
Carrier Global Corp. (CARR)+0.53 %USD 56.25USD 46.6 bn
Exelon Corp. (EXC)+0.05 %USD 44.28USD 44.4 bn
State Street Corp. (STT)+1.42 %USD 167.18USD 45.5 bn
  • The most recent 24‑hour trading session for DR Horton ended at 06:00 PM Central Europe on Thursday 22 October 2026, with a decline of 0.85 %.
  • The 24‑hour volume for DR Horton was approximately USD 332.3 million.
  • Since the previous month‑end, the stock has fallen 3.56 %.
  • The 200‑day simple moving average is USD 147.8.
  • The 52‑week high and low for the stock were USD 170.79 (25 June 2026) and USD 130.40 (14 October 2026), respectively.

Market Capitalisation and Supply

  • DR Horton’s current market capitalisation is USD 38.9 bn.
  • Outstanding shares total 279.7 million.
  • State Street Corp. issued new debt instruments on 20 October 2026, including $750 million of Fixed‑to‑Floating Rate Senior Notes due 2037 and $500 million of Floating‑Rate Senior Notes due 2028, with net proceeds projected near USD 1.25 bn.

  • Ferguson Enterprises Inc. filed a Form 4 reporting a sale of common stock by an officer under a Rule 10b5‑1 trading plan; no other corporate actions were disclosed.

Analyst Commentary

  • Idexx Laboratories: Analysts highlighted its recurring revenue model, driven by consumable sales and repeat testing, and noted upcoming product launches and software enhancements that could expand its market reach. The firm’s recent quarter exceeded revenue and earnings forecasts, supporting a positive outlook for its share price.

  • Carrier Global: The company’s share price moved in response to broader euro‑zone bond market dynamics, with French borrowing costs rising and affecting political and fiscal stability perceptions. The impact on Carrier’s valuation was modest, reflecting the company’s diversified operations.

Company Profile – DR Horton

DR Horton Inc. is a publicly traded construction and home‑sales company focused on single‑family homes for entry‑level and move‑up buyers. Its operations span the Midwest, Mid‑Atlantic, Southeast, Southwest, and Western United States. The company also provides mortgage financing and title services through its financial services division. DR Horton is listed on the New York Stock Exchange; its IPO was conducted on 5 June 1992.

For further information, visit the company’s website at www.drhorton.com .